Diagens-B (02526) has announced its inclusion in 23 Hang Seng Indexes managed by Hang Seng Indexes Company Limited, a move that takes effect in stages starting September 2026.
The inclusions cover three key categories: the Hang Seng Composite Index alongside the Hang Seng Composite LargeCap & MidCap Index, effective Monday, September 7, 2026; the Hang Seng Biotechnology Index, effective Monday, September 14, 2026; and the Hang Seng Stock Connect AI Theme Index, also effective Monday, September 14, 2026.
Being added to these indices marks a significant milestone for the company, as it now meets the criteria for inclusion in the Stock Connect program. Stock Connect serves as a vital channel connecting investors in Hong Kong with the broader capital markets in mainland China, facilitating cross-border stock trading and investment opportunities.
The board believes that the company's selection for the Hang Seng Composite Index, the Hang Seng Biotechnology Index, and the Hang Seng Stock Connect AI Theme Index reflects the capital market's recognition of and confidence in the company's long-term growth potential.
Furthermore, this milestone is expected to pave the way for the company's shares to be incorporated into the core portfolios of a wider range of index funds and institutional investors. This development is anticipated to diversify the investor base, enhance trading liquidity, and strengthen the company's resilience against market volatility.